IOL Chemicals & Pharmaceuticals informs about trading window closure

IOL Chemicals And Pharmaceuticals Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 524164 | NSE: IOLCP

26 Mar 2025 Evaluate

Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company’s ‘Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons’, IOL Chemicals & Pharmaceuticals has informed that it enclosed the Trading Window for dealing in the securities of the Company, shall remain closed for the designated persons from 1st April 2025 till the expiry of 48 hours after the financial results for the quarter and year ended 31 st March 2025 are made public. The date of the Board Meeting for approving the financial results will be communicated in due course.

The above information is a part of company’s filings submitted to BSE.

Peers

Company Name	CMP
Sun Pharma. Inds.	1842.55
Dr. Reddys Labs.	1141.00
Cipla	1366.30
Lupin	2075.00
Zydus Lifesciences	1113.45
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.